Potent sulfatase inhibitors that are metabolically stable, selective and devoid of estrogenic activity

摘要

Sulfatase inhibitor compounds useful in the treatment of oestrogen dependent illnesses are disclosed. These compounds generally comprise a steroid nucleus substituted at the C17 position. Methods for synthesizing these compounds and using them in the therapeutic and/or prophylactic treatment of a patient are also disclosed.